Evidence map›Paper›PMID 40904449›Full record

ArticleJournal of general and family medicine2025

Effects of a two-night hospitalization program as a specific health guidance on obesity and cardiovascular disease risk factors.

Maki Okazaki, Takeshi Katsuki, Hideaki Kurata, Shinichi Tanaka, Hajime Tanaka, Toshihide Kawai

Abstract read
In one paragraph

Article in Journal of general and family medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maki OkazakiFrom the Department of Internal Medicine Tokyo Saiseikai Central Hospital Tokyo Japan.ORCID https://orcid.org/0009-0003-4717-6302
Takeshi KatsukiFrom the Department of Internal Medicine Tokyo Saiseikai Central Hospital Tokyo Japan.
Hideaki KurataFrom the Department of Internal Medicine Tokyo Saiseikai Central Hospital Tokyo Japan.
Shinichi TanakaFrom the Department of Internal Medicine Tokyo Saiseikai Central Hospital Tokyo Japan.
Hajime TanakaFrom the Department of Internal Medicine Tokyo Saiseikai Central Hospital Tokyo Japan.
Toshihide KawaiFrom the Department of Internal Medicine Tokyo Saiseikai Central Hospital Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To assess the effects of a two-night hospitalization program conducted at our hospital as part of a domestic health guidance system. This program is designed for lifestyle modification within a health checkup framework for metabolic syndrome. Methods: This is a single-center, retrospective observational study. We reviewed the medical records of 170 subjects who completed the two-night hospitalization program between June 1, 2019, and October 31, 2023. The ideal dietary caloric intake was calculated based on standard body weight (kg) × 25 kcal/kg. Participants were advised to maintain a regular lifestyle and received face-to-face instruction from nurses, nutritionists, physiotherapists, technicians, and physicians. We instructed the patients to visit the outpatient clinic twice, one month and three months after discharge. We compared body weight, systolic and diastolic blood pressure, and various metabolic parameters from those recorded before the program to the final outpatient visit after the program. Results: Roughly half of the participants had been previously diagnosed with obesity and metabolic syndrome. At the second outpatient visit after completing the program, participants showed a significant body weight reduction (71.6 ± 13.5 kg vs. 70.1 ± 13.3 kg, Conclusions: The findings suggest that the two-night hospitalization program may offer significant benefits for managing coronary risk factors associated with metabolic syndrome.

Indexed as

lifestyle modificationmetabolic syndromeobesityspecific health guidance

Identifiers

PMID40904449
PMCPMC12404171

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.